CLINICAL TRIALS | Transition to Clinical Trials Regulation EU 536/2014 and CTIS

January 22, 2024

Only a year left for the transition!

At Asphalion we can give you support for the clinical trials transition into the clinical trials regulation EU 536/2014 and CTIS. This online system will be implemented in the European Union, as well as in the European Economic Area for the regulatory submission, authorization and supervision of Clinical Trials (CTs).

From now on, there is going to be a single-entry point for all Clinical Trial (CT) data, and CTIS allows sponsors to apply to the 30 EU/EEA countries through a single application.

This new procedure will be mandatory for all the CTs authorized under the previous Directives and they must transition to the new CTR and CTIS before January 31st, 2025.

At Asphalion we count with a team of experts specialized in CTIS platform and CTR EU 536/2014. Their deep knowledge in European Regulation allows us to provide you with a comprehensive, multidisciplinary, and transversal support for successful management of CTs. Our experts are involved in the management and coordination of the procedure and possess technical expertise of non-clinical, clinical and CMC technical documents.

For a successful transition of a CT to CTIS, Asphalion can provide you with:

  • Transition strategy: understanding of the trial context and Client’s situation to determine complexity of the transition and requirements.
  • Assistance in prioritization of CTs for transition, according to a defined strategy, evaluating the most effective transition plan and calendar in the case of sponsors managing multiple CTs.
  • Analysis of documentation, including technical analysis, if appropriate, for their adaptation to CTR and for its homogenization in the case of multi-country CTs.
  • Management of the transition process: set up of the project, appointment of roles and permissions, preparation and Review of documentation for Parts I and II, adaptation of documents to Transparency Regulation, management of Requests for Information, and follow-up with National Competent Authorities.
  • CT lifecycle management.
  • Ad-hoc consultancy.

 

ASPHALION CLINICAL TRIALS TRANSITION

Need help? Contact us at: info@asphalion.com

Or schedule a free 30-minutes meeting here: https://bit.ly/3NwVsNR

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting